PHARMACOLOGICAL INHIBITION OF ADENYLYL CYCLASE TYPE 5: A NOVEL THERAPEUTIC MODALITY TO REDUCE INFARCT SIZE EVEN WHEN DELIVERED AFTER CORONARY ARTERY REPERFUSION

20180 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of the American College of Cardiology

Volume 71, Issue 11, pp. A9-A9

Field-Weighted Citation Impact: 0.00